Authors: Polevaya, L Mavromoustakos, T Zoumboulakis, P Grdadolnik, SG Roumelioti, P Giatas, N Mutule, I Keivish, T Vlahakos, DV Iliodromitis, EK Kremastinos, DT Matsoukas, J

Citation: L. Polevaya et al., Synthesis and study of a cyclic angiotensin II antagonist analogue revealsthe role of pi-pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists, BIO MED CH, 9(6), 2001, pp. 1639-1647

Authors: Matsoukas, JM Polevaya, L Ancans, J Mavromoustakos, T Kolocouris, A Roumelioti, P Vlahakos, DV Yamdagni, R Wu, Q Moore, GJ

Citation: Jm. Matsoukas et al., The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II, BIO MED CH, 8(1), 2000, pp. 1-10

Authors: Roumelioti, P Tselios, T Alexopoulos, K Mavromoustakos, T Kolocouris, A Moore, GJ Matsoukas, JM

Citation: P. Roumelioti et al., Structural comparison between type I and type II antagonists: Possible implications in the drug design of AT1 antagonists, BIOORG MED, 10(8), 2000, pp. 755-758

Authors: Mavromoustakos, T Kolocouris, A Zervou, M Roumelioti, P Matsoukas, J Weisemann, R

Citation: T. Mavromoustakos et al., An effort to understand the molecular basis of hypertension through the study of conformational analysis of Losartan and Sarmesin using a combinationof nuclear magnetic resonance spectroscopy and theoretical calculations, J MED CHEM, 42(10), 1999, pp. 1714-1722